Relationship of demographic and clinical factors to free and total prostate-specific antigen.

[1]  John K. Gohagan,et al.  The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial , 2000 .

[2]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. , 1999, Journal of the National Cancer Institute.

[3]  G. Bartsch,et al.  Association of free PSA percent, total PSA, age, and gland volume in the detection of prostate cancer , 1999, The Prostate.

[4]  M. Miller,et al.  Free/total PSA ratio improves differentiation of benign and malignant disease of the prostate: critical analysis of two different test populations. , 1999, Urology.

[5]  S. Egawa,et al.  Significance of free to total PSA ratio in men with slightly elevated serum PSA levels: a cooperative study. , 1998, Japanese journal of clinical oncology.

[6]  H. Klocker,et al.  Improvement of specificity in PSA‐based screening by using PSA‐transition zone density and percent free PSA in addition to total PSA levels , 1998, The Prostate.

[7]  Srinivasan Vijayakumar,et al.  Race and serum prostate-specific antigen levels: current status and future directions. , 1998, Seminars in urologic oncology.

[8]  A. Kochańska-Dziurowicz,et al.  The clinical utility of measuring free-to-total prostate-specific antigen (PSA) ratio and PSA density in differentiating between benign prostatic hyperplasia and prostate cancer. , 1998, British journal of urology.

[9]  T. Piironen,et al.  Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levels. , 1998, British journal of urology.

[10]  M. Solomon,et al.  Age specific prostate specific antigen reference ranges: population specific. , 1998, The Journal of urology.

[11]  Srinivasan Vijayakumar,et al.  Comparison of serum prostate-specific antigen levels and PSA density in African-American, white, and Hispanic men without prostate cancer. , 1998, Urology.

[12]  W. Sause,et al.  Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12. , 1998, International journal of radiation oncology, biology, physics.

[13]  W. Catalona,et al.  Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. , 1998, The Journal of urology.

[14]  A. Whittemore,et al.  Serum levels of prostate-specific antigen among Japanese-American and native Japanese men. , 1997, Journal of the National Cancer Institute.

[15]  Clinical evaluation of free PSA/total PSA (prostate-specific antigen) ratio in the diagnosis of prostate cancer. , 1997, European journal of cancer.

[16]  D. Ornstein,et al.  Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. , 1997, JAMA.

[17]  Kao Ch.  Age-related free PSA, total PSA and free PSA/total PSA ratios: establishment of reference ranges in Chinese males. , 1997 .

[18]  H. Klocker,et al.  Improvement of prostate cancer screening by determination of the ratio free/total PSA in addition to PSA levels , 1997, The Prostate.

[19]  E. Metter,et al.  Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer. , 1996, Urology.

[20]  J. Oesterling,et al.  Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study. , 1996, Urology.

[21]  J. Moul,et al.  Age-specific reference ranges for serum prostate-specific antigen in black men. , 1996, The New England journal of medicine.

[22]  D. Johnson,et al.  Prostate-specific antigen concentration: influence of age and ethnicity. , 1995, Hawaii medical journal.

[23]  J. Richie,et al.  Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. , 1994, The Journal of urology.

[24]  Barnett Kramer.  Prostate Cancer Screening , 1994, Annals of Internal Medicine.

[25]  P C Prorok,et al.  Prostate Cancer Screening: What We Know and What We Need To Know , 1993, Annals of Internal Medicine.

[26]  O. Nilsson,et al.  Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. , 1993, The Journal of urology.

[27]  W. Rosner,et al.  Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. , 1990, The Journal of clinical endocrinology and metabolism.

[28]  L. Pogach,et al.  Effects of chronic smoking on testosterone metabolism in dogs. , 1983, Journal of steroid biochemistry.